|
|
|
| Clinical study and present situation of the treatment of heart disease and psychology to the patients with coronary heart disease after percutaneous coronary intervention |
| LI Yiping WANG Xiaolong▲ |
| Department of Cardiovascular, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Institute of Cardiovascular Disease, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China |
|
|
|
|
Abstract The morbidity and mortality rate of coronary heart disease (CHD) is on the rise in China, and percutaneous coronary intervention (PCI) is one of the main methods to diagnose and treat CHD. However, for most patients, the risk of disease and surgical treatment, stent-induced economic problems, postoperative restenosis, stent thrombosis and other factors will give the patients physical and mental burden, which are easy to generate anxiety, depression and other emotion problems, severe cases can even affect the efficacy and quality of life. Therefore, while physicians treat patients with active heart diseases, they also need pay attention to psychological problems that may accompany the heart diseases. And timely intervention by heart physicians can make the patient get the heart, psychological harmony and unity. This article mainly gives a brief summary of the related research progress on the psychological problems, causes, diagnosis and treatment after PCI.
|
|
|
|
|
|
[1] 陈伟伟，高润霖，刘力生，等.《中国心血管病报告2015》概要[J].中国循环杂志，2016，31（6）：521-528.
[2] Lichtman JH，Froelicher ES，Blumenthal JA，et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome：systematic review and recommendations：a scientific statement from the American Heart Association [J]. Circulation，2014，129（12）：1350-1369.
[3] van Dijk MR，Utens EM，Dulfer K，et al. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up [J]. Eur J Prev Cardiol，2015， 54（3）：277-283.
[4] Astin F，Jones K，Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty [J]. Heart Lung，2005，34（6）：393-401.
[5] 马文林.重视双心医学原创研究[J].医学与哲学，2017， 38（3）：8-10.
[6] Damen NL，Versteeg H，Boersma E，et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention：results from the RESEARCH registry [J]. Int J Cardiol，2013，167（6）：2496-2501.
[7] Park JH，Tahk SJ，Bae SH. Depression and Anxiety as Predictors of Recurrent Cardiac Events 12 Months After Percutaneous Coronary Interventions [J]. J Cardiovasc Nurs，2014，30（4）：351-359.
[8] Gu G，Zhou Y，Ying Z，et al. Increased prevalence of anxiety and depression symptoms in patients with coronary artery disease before and after percutaneous coronary intervention treatment [J]. BMC Psychiatry，2016，16（1）：259.
[9] Furuya RK，Costa EC，Coelho M，et al. Anxiety and depression among men and women who underwent percutaneous coronary intervention [J]. Rev Esc Enferm USP，2013， 47（6）：1333-1337.
[10] Denollet J，Pedersen SS，Ong AT，et al. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era [J]. Eur Heart J，2006，27（2）：171-177.
[11] Al-Qezweny MN，Utens EM，Dulfer K，et al. The association between type D personality，and depression and anxiety ten years after PCI [J]. Neth Heart J，2016，24（9）：538-543.
[12] Dulfer K，Hazemeijer BA，Van Dijk MR，et al. Prognostic value of type D personality for 10-year mortality and subjective health status in patients treated with percutaneous coronary intervention [J]. J Psychosom Res，2015， 79（3）：214-221.
[13] Kala P，Hudakova N，Jurajda M，et al. Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI [J]. Plos One，2016，11（4）：e0152367.
[14] 中国康复学会心血管病专业委员会.在心血管科就诊患者的心理处方中国专家共识[J].中华心血管病杂志，2014，42（1）：6-13.
[15] Adibfar A，Saleem M，Lanctot KL，et al. Potential Biomarkers for Depression Associated with Coronary Artery Disease：A Critical Review [J]. Curr Mol Med，2016，16（2）：137-164.
[16] The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction：the Enhancing Recovery in Coronary Heart Disease Patients（ENRICHD）randomized trial [J]. JAMA，2003，289（23）：3106-3116.
[17] Blumenthal JA，Babyak MA，Moore KA，et al. Effects of exercise training on older patients with major depression [J]. Arch Intern Med，1999，159（19）：2349-2356.
[18] Babyak M，Blumenthal JA，Herman S，et al. Exercise treatment for major depression：maintenance of therapeutic benefit at 10 months [J]. Psychosom Med，2000，62（5）：633-638.
[19] Lv J，Zhang X，Ou S，et al. Influence of Cognitive Behavioral Therapy on Mood and Quality of Life After Stent Implantation in Young and Middle-Aged Patients With Coronary Heart Disease [J]. Int Heart J，2016，57（2）：167-172.
[20] Blumenthal JA，Sherwood A，Babyak MA，et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease：results from the UPBEAT（Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy）study [J]. JACC，2012， 60（12）：1053-1063.
[21] Lesperance F，Frasure- Smith N，Koszycki D，et al. Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy（CREATE）Tria [J]. JAMA，2007，297（4）：367-379.
[22] Rafanelli C，Sirri L，Grandi S，et al. Is depression the wrong treatment target for improving outcome in coronary artery disease? [J]. Psychother Psychosom，2013，82（5）：285-291.
[23] 丁荣晶.双心医学研究进展[J].四川精神卫生，2014，27（3）：193-197.
[24] Shahmansouri N，Farokhnia M，Abbasi SH，et al. A randomized，double-blind，clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients [J]. J Affect Disord，2014，155：216-222.
[25] 万书平，杨广龙，尹琼，等.心可舒片治疗冠心病PCI术后焦虑抑郁效果观察[J].中西医结合心脑血管病杂志，2013，11（11）：1323. |
|
|
|
